Best Oral 2017

ESGO 2017 Vienna Congress

Best Oral Presentations Award Winners

 

  • ARIEL3: PHASE 3, RANDOMISED, DOUBLE-BLIND STUDY OF RUCAPARIB  VS PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA (OC) 

Jonathan Ledermann, United Kingdom 

View More Info

Watch webcast

 

  • LION – LYMPHADENECTOMY IN OVARIAN NEOPLASMS. A PROSPECTIVE RANDOMIZED AGO STUDY GROUP LED GYNECOLOGIC CANCER INTERGROUP TRIAL 

 

Domenica Lorusso, Italy 

View More Info

Watch Webcast

  

  • AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT-INTERGROUP PHASE III TRIAL WITH CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER: OVERALL SURVIVAL RESULT

 

Isabelle Ray-Coquard, France 

View More Info

Watch Webcast

 

 

  • RANDOMIZED CONTROLLED PHASE III STUDY TO EVALUATE SECONDARY CYTOREDUCTIVE SURGERY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER - AGO DESKTOP III/ENGOT OV20 

   Jalid Sehouli, Germany

   View More Info

    

  • PERIOPERATIVE POSITIONING MANAGEMENT IN GYNECOLOGIC CANCER SURGERY: A NATIONAL NOGGO-AGO INTERGROUP SURVEY 
      

  Jenny Katharina Wagner, Germany 
  View More Info

 

  • NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 UNDER ACTIVE SURVEILLANCE – A SYSTEMATIC REVIEW AND META-ANALYSIS 

       Karoliina Tainio, Finland 

       View More Info

 

  • POTENTIAL CLINICAL IMPACT OF THE INTRODUCTION OF THE NONAVALENT HUMAN PAPILLOMAVIRUS VACCINATION: AN ANALYSIS OF 13,665 PATIENTS OVER A 18-YEAR STUDY PERIOD 

  Giorgio Bogani, Italy 

  View More Info

 

  • REFINEMENT OF HIGH-RISK ENDOMETRIAL-CANCER (HR-EC) CLASSIFICATION USING DNA DAMAGE RESPONSE (DDR) BIOMARKERS: A TRANSPORTEC INITIATIVE

  Aurélie Auguste, France

 

  • SENSITIVITY OF NON-INVASIVE PRENATAL FOR CANCER DETECTION AND TREATMENT MONITORING
    IN PREGNANT WOMEN

  Liesbeth Lenaerts, Belgium

 

  • THE NEW NORMAL; SEXUAL FUNCTION AFTER OVARIAN CANCER FOR SURVIVORS AND PARTNERS COMPARED TO NORMDATA 

  M.Caroline Vos, The Netherlands

  View More Info

 

  • COMPLIANCE TO ADJUVANT TREATMENT GUIDELINES IN ENDOMETRIAL CANCER: ROOM
    FOR IMPROVEMENT IN HIGH RISK PATIENTS 

  Florine Eggink, The Netherlands 

  View More Info

 

  • EXPRESSION OF L1CAM IN CURETTAGE AND HIGH L1CAM LEVEL IN PREOPERATIVE BLOOD SAMPLES PREDICTS LYMPH NODE METASTASES AND POOR OUTCOME IN ENDOMETRIAL CANCER PATIENTS 

  Ingvild Loberg Tangen, Norway 

  View More Info

 

  • PRETERM BIRTH AND CONIZATION PRIOR TO PREGNANCY: AN ANALYSIS OF THE NATIONAL INPATIENT QUALITY SURVEY DATA IN GERMANY; 2009-2014. 

  Christian Dannecker, Germany

  View More Info

Upcoming events

banner web 194x170

Surgery Course

Ovarian Cancer Surgery Course
Mar 22-24, 2018, Hamburg, Germany

Apply Now!

Read More

ESGO 2018 294X170

Conference

ESGO State of the Art 
Oct 4-6, 2018, Lyon, France

Save the Date!

Read More

athens 294x174

Congress

ESGO 21st CONGRESS
Nov 2-5, 2019, Athens, Greece

Save the Date!

Read More